Details van artikel 132 van 426 gevonden artikelen
164 ENGOT-cx11/GOG 3047/KEYNOTE-A18: a phase 3, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer
Titel:
164 ENGOT-cx11/GOG 3047/KEYNOTE-A18: a phase 3, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer
Auteur:
Lorusso, D. Colombo, N. Coleman, R. Randall, L. Duska, L. Xiang, Y. Hasegawa, K. Nogueira-Rodrigues, A. Cibula, D. Raza Mirza, M. You, B. Oaknin, A. Christiaens, M. Taskiran, C. Sehouli, J. Korach, J. Martin, C. Keefe, S. Puglisi, M. Pignata, S.
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 30 () nr. S3 pagina's A71
Jaar:
2020
Inhoud:
Uitgever:
Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 132 van 426 gevonden artikelen